This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
DKK3 / Dickkopf-related protein 3 · IHC design guide
Design Immunohistochemistry for DKK3
Plan DKK3 chromogenic IHC in paraffin sections using the catalog antibody’s 1:50 starting dilution (datasheet A02248-2). Compare staining with the generally cytoplasmic tissue pattern and high neuronal staining in caudate and hippocampus (HPA tissue IHC).
Evidence assembled Oct 2026 · For research use; verify linked source records and product datasheet before use
DKK3 Immunohistochemistry Experimental Design Guide
Expected localisation, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
Must know before staining
| Expected localisation | Cytoplasmic staining (HPA tissue IHC); secreted (UniProt) | |
| Staining pattern | High neuronal staining; generally cytoplasmic (HPA tissue IHC) | |
| Antigen retrieval | EDTA pH 8.0 HIER, heat-mediated (datasheet A02248-2) | |
| Positive control | Caudate+4 more · see all | |
| Negative control | Lymph node+1 more · see all |
Important caveats
Reasons your staining may differ from the expected pattern.
| Fixation | Keep fixation consistent across paraffin sections (standard IHC practice; not target-specific) | |
| Caveat | Secreted DKK3 may stain away from RNA-positive cells (HPA tissue IHC) | |
| Regulation | Expression regulation is not specified (UniProt record) | |
| Isoform / epitope | No isoforms annotated; mature chain starts at 22 (UniProt) |
Section 1
Recommended DKK3 IHC & IF Protocols
The catalog antibody protocol uses EDTA pH 8.0 retrieval (datasheet A02248-2). The four published DKK3 IHC protocols below cover cartilage, glioblastoma, oral biopsies, and bladder cancer tissue (PMC12645725; PMC11012478; PMC4933828; PMC7150467).
| Sample | Paraffin-embedded human brain tissue; fixative not specified (datasheet A02248-2) |
| Fixation | Image fixative and duration unreported (datasheet A02248-2); verify before use. |
| Sectioning | 4–5 µm sections on charged slides (standard) |
| Deparaffinisation | Xylene, graded ethanol series to water (standard) |
| Antigen retrieval | Heat retrieval: EDTA pH 8.0 (datasheet A02248-2); 20 min, 95–100 °C (standard) |
| Peroxidase block | 3% H2O2, 10 min, room temperature (standard) |
| Blocking | 10% goat serum (datasheet A02248-2) |
| Primary antibody | Rabbit anti-DKK3, 1:50 recommended; image 2 μg/ml (datasheet A02248-2) |
| Primary incubation | Overnight at 4 °C (datasheet A02248-2) |
| Detection | HRP-conjugated secondary, DAB chromogen (datasheet A02248-2) |
| Counterstain | Hematoxylin, blue, dehydrate and mount (standard) |
| Expected result | DKK3-positive staining in neuronal cells of caudate (HPA tissue IHC: High). HPA tissue profile: General cytoplasmic expression. No signal in the no-primary control. |
💡Decision noteStart with heat-mediated EDTA pH 8.0 for the catalog antibody (datasheet A02248-2). Published protocols used citrate pH 6.0 with other antibodies (PMC11012478; PMC4933828).
Section 2
What Is the Expected DKK3 Staining Pattern?
DKK3 is secreted, has a signal peptide and lacks a transmembrane segment (UniProt Q9UBP4 topology). In tissue IHC, expect mainly cytoplasmic staining, especially in caudate and hippocampal neuronal cells, where HPA reports high staining (HPA tissue IHC). HPA rates its tissue IHC profile Approved but reports low consistency with RNA; secretion can separate the sites of RNA expression and protein staining (HPA tissue IHC).
| Strong cytoplasmic staining in caudate or hippocampal neurons. | This matches HPA's high neuronal staining and general cytoplasmic tissue profile (HPA tissue IHC). Judge the signal by cell identity and compartment as well as intensity; a positive control should reproduce that distribution. |
| Predominant nuclear staining, with little cytoplasmic signal. | This departs from the general tissue IHC pattern (HPA tissue IHC). HPA describes nuclear bodies only as an uncertain additional ICC-IF location (HPA subcellular); dominant nuclear IHC staining therefore needs artifact and antibody-specificity checks before interpretation. |
| Strong staining in lymph-node germinal-center cells. | HPA reports these cells as not detected (HPA tissue IHC). Recheck cell identification, the no-primary control and detection background; unexpected staining may reflect cross-reactivity or endogenous detection activity (standard IHC practice). |
| Diffuse chromogen across cells, stroma and the section edge. | A distribution unrelated to the HPA cell pattern is difficult to score as DKK3 (HPA tissue IHC). Section-wide signal may arise from nonspecific binding or detection background; a secreted target alone does not explain uniform staining (UniProt Q9UBP4; standard IHC practice). |
| No signal in caudate or hippocampal neurons. | These are HPA high-staining cells, so absent signal calls the staining run into question (HPA tissue IHC). Check tissue preservation, retrieval, antibody dilution and detection controls before treating the result as biological absence (standard IHC practice). |
💡Expected DKK3 appearanceA credible positive is high cytoplasmic staining in caudate or hippocampal neurons (HPA tissue IHC); dominant nuclear staining or strong germinal-center staining calls for validation (HPA subcellular; HPA tissue IHC).
| Secretion and topology | DKK3 has a signal peptide at residues 1–21, a mature chain at 22–350, and no transmembrane segment (UniProt Q9UBP4 topology). Interpret tissue signal in its cell context; protein staining need not coincide with the cells showing the most RNA (HPA tissue IHC). |
| Glycosylation and processing | UniProt lists 6 glycosylation sites and no propeptide (UniProt Q9UBP4). These annotations describe DKK3 processing; they do not establish an IHC epitope, retrieval requirement or fixation sensitivity. |
| Tissue and cell choice | Caudate and hippocampal neurons are high-staining reference cells; adrenal and appendix glandular cells show medium staining (HPA tissue IHC). Germinal-center cells are a reported not-detected comparator, but their absence of staining does not validate every positive signal (HPA tissue IHC). |
| Strength of tissue evidence | The HPA tissue profile is Approved, with low consistency between antibody staining and RNA expression (HPA tissue IHC). HPA lists HPA011868 and CAB024949 as IHC Approved; this payload does not report an Enhanced IHC classification (HPA antibodies). |
| IF/ICC comparison | Q: Should IF/ICC look identical to tissue IHC? A: HPA supports vesicles as the main ICC-IF location; nuclear bodies and cytosol are uncertain additional locations (HPA subcellular). Compare each application with its own observed pattern. |
| Situation | Likely cause | Next action |
|---|---|---|
| Positive-control neurons are blank. | The observed result conflicts with HPA's high caudate and hippocampal neuronal staining (HPA tissue IHC); the failed step is undetermined. | Review section quality, retrieval, antibody dilution, detection reagents and a run control systematically (standard IHC practice). Do not assign DKK3 absence from this run alone. |
| The whole section is brown. | Uniform signal does not follow HPA's cell-specific tissue observations (HPA tissue IHC). Nonspecific binding or detection background is possible (standard IHC practice). | Inspect a no-primary control; review blocking, washes, detection chemistry and development time (standard IHC practice). Reassess the pattern only after background is controlled. |
| Germinal-center cells stain strongly. | HPA reports no detected staining in these cells (HPA tissue IHC). Cross-reactivity or endogenous detection activity is possible, depending on the detection system (standard IHC practice). | Confirm cell identity and examine no-primary and detection-only controls (standard IHC practice). Treat the signal as unresolved until its source is established. |
| Nuclei dominate the signal. | General cytoplasmic tissue staining is expected (HPA tissue IHC); nuclear bodies are an uncertain ICC-IF observation, not an established dominant IHC pattern (HPA subcellular). | Compare a known-positive section and controls, then review antibody and detection conditions (standard IHC practice). Avoid scoring isolated nuclear signal as confirmed DKK3. |
| Heart staining seems inconsistent with an RNA-based expectation. | UniProt reports high heart expression, while HPA reports enhanced heart-muscle RNA and warns that secreted protein staining may differ from RNA location (UniProt Q9UBP4; HPA tissue IHC). | Record the actual stained cell type and compartment. Use the observed IHC pattern and matched controls for interpretation rather than treating RNA abundance as a staining map (HPA tissue IHC). |
| A proposed retrieval or fixation change is described as DKK3-specific. | Target-specific fixation effects are not established by the supplied assay evidence. Verify with a matched IHC source before attributing a result to fixation. | Treat retrieval adjustment as general paraffin-IHC optimization and compare controlled sections (standard IHC practice). Do not claim a target-specific effect without direct evidence. |
Experiment evidence
IHC & IF images showing DKK3 staining
A02248-2 · IHCIHC analysis of DKK3 using anti-DKK3 antibody (A02248-2). DKK3 was detected in a paraffin-embedded section of human brain tissue. Heat media
A02248-1 · IHCFormalin-fixed and paraffin-embedded human brain tissue reacted with DKK3 antibody (N-term) , which was peroxidase-conjugated to the seconda
A02248-1 · IHCFormalin-fixed and paraffin-embedded human breast carcinoma tissue reacted with DKK3 Antibody (N-term), which was peroxidase-conjugated to t
HPA · Cerebral cortexHuman Protein Atlas IHC, Cerebral cortex. Source: https://www.proteinatlas.org/ENSG00000050165-DKK3/tissue/cerebral+cortex#imid_3131264
HPA · ColonHuman Protein Atlas IHC, Colon. Source: https://www.proteinatlas.org/ENSG00000050165-DKK3/tissue/colon#imid_3131182
HPA · LiverHuman Protein Atlas IHC, Liver. Source: https://www.proteinatlas.org/ENSG00000050165-DKK3/tissue/liver#imid_3131183
HPA · KidneyHuman Protein Atlas IHC, Kidney. Source: https://www.proteinatlas.org/ENSG00000050165-DKK3/tissue/kidney#imid_3131184
HPA · ICC-IF A-431Human Protein Atlas immunofluorescence, A-431, antibody HPA011868; green = DKK3, blue = nucleus, red = microtubules.
HPA · ICC-IF A-431Human Protein Atlas immunofluorescence, A-431, antibody HPA011868; green = DKK3, blue = nucleus, red = microtubules.
← swipe / scroll for more images →
Real IHC / IF data behind the staining-pattern expectations in this section.
Sample controls for DKK3 IHC & IF
🧪Run caudate first and score neuronal cells, which show High DKK3 staining (HPA: caudate neuronal cells, High); use lymph node germinal center cells as the negative tissue (HPA: lymph node germinal center cells, Not detected). On the caudate slide, use any morphologically identified non-neuronal cells that lack signal as internal background references, without assuming every non-neuronal cell is DKK3-negative (HPA: caudate neuronal cells, High).
Positive control tissue: Caudate (Neuronal cells, HPA High)
Negative control tissue: Lymph node (HPA Not detected)
ICC-IF cell lines (HPA subcellular resource): HPA ICC-IF images show DKK3 in A-431, BJ [Human fibroblast], U2OS, with annotated localisation: Vesicles (supported) (HPA subcellular).
Technical controls: Include a no-primary, secondary-only control, a concentration-matched rabbit IgG isotype control matched to the primary antibody’s clonality, and DKK3 knockout tissue or cells as a biological negative (caption: rabbit anti-DKK3 antibody). For chromogenic brain IHC, quench endogenous peroxidase and assess background before interpreting DAB signal (caption: human brain tissue; HRP/DAB detection).
⚠️Feasibility: A target-specific fixation window and fixation effect are unreported, and the selected A02248-2 tissue-IHC caption does not state the fixative (caption: fixative not stated). The paraffin-section example used heat-mediated EDTA retrieval at pH 8.0, providing a starting condition; the evidence does not establish whether frozen sections or IF are easier (caption: paraffin section, EDTA retrieval). In brain sections, distinguish specific staining from tissue pigment and, for IF, autofluorescence (caption: human brain tissue; standard IHC/IF practice).
HPA tissue IHC evidence for DKK3
Comprehensive Human Protein Atlas IHC scoring per tissue (reliability: Approved — Low consistency between antibody staining and RNA expression data. Secreted protein, tissue location of RNA and protein is expected to differ.). Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
Positive expression · recommended positive controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Caudate | Neuronal cells | High | Protein (IHC) | HPA → |
| Hippocampus | Neuronal cells | High | Protein (IHC) | HPA → |
| Adrenal gland | Glandular cells | Medium | Protein (IHC) | HPA → |
| Appendix | Glandular cells | Medium | Protein (IHC) | HPA → |
| Breast | Glandular cells | Medium | Protein (IHC) | HPA → |
Section 3
Advanced DKK3 IHC Tips
Troubleshoot DKK3 staining in paraffin sections using the catalog antibody’s tissue example, protein biology, and tissue staining patterns as separate lines of evidence.
What retrieval should I try first when DKK3 staining is weak?
Start with heat-mediated retrieval in EDTA at pH 8.0 for paraffin sections (datasheet A02248-2). The catalog antibody’s human brain example used that retrieval, followed by 10% goat-serum blocking and 2 μg/ml primary antibody overnight at 4°C (datasheet A02248-2). If staining remains weak, vary heating duration on matched sections while keeping detection and exposure comparable; record the time and check whether tissue structure deteriorates (general IHC practice). Use an appropriate positive section alongside each trial, since high neuronal-cell staining in caudate and hippocampus provides a tissue-based expectation, not a guaranteed result for every specimen (HPA tissue IHC: High in neuronal cells).
How should I assess whether fixation is causing weak DKK3 staining?
The selected human brain caption describes a paraffin-embedded section but does not report its fixative, so target-specific DKK3 sensitivity to fixation is unknown (datasheet A02248-2: fixative not stated). Compare sections with documented fixation histories using the same EDTA pH 8.0 retrieval, antibody concentration, and detection conditions before attributing a difference to fixation (datasheet A02248-2; general IHC practice). Inspect morphology and compare intact regions at matched staining times, because uneven processing can complicate a staining comparison (general IHC practice). Record fixation type and duration for each specimen; neither tissue staining patterns nor DKK3’s secreted topology establishes a preferred fixative (HPA tissue IHC; UniProt Q9UBP4 topology).
Where should convincing DKK3 staining appear in a tissue section?
Assess cytoplasmic and potentially extracellular signal in the context of a secreted protein: tissue IHC is described as generally cytoplasmic, and DKK3 lacks a transmembrane segment (HPA tissue IHC: general cytoplasmic expression; UniProt Q9UBP4 topology). High neuronal-cell staining in caudate and hippocampus offers useful section-level comparators (HPA tissue IHC: High in neuronal cells). Vesicles are the supported location in cellular imaging, whereas nuclear bodies and cytosol have uncertain support; that imaging does not establish a nuclear tissue-IHC pattern (HPA subcellular: supported vesicles; uncertain nuclear bodies and cytosol). Compare cell-associated staining with adjacent extracellular material and morphology before assigning either signal to a particular producing cell (UniProt Q9UBP4: Secreted; general IHC practice).
Could DKK3 processing or glycosylation change what the antibody detects?
DKK3 has a 1–21 signal peptide and a reported 22–350 mature chain, so an epitope’s position matters when assessing recognition of processed protein (UniProt Q9UBP4 processing). Six glycosylation sites are annotated at residues 26, 28, 96, 106, 121, and 204, but their effect on this antibody’s tissue staining is unreported (UniProt Q9UBP4 glycosylation; datasheet A02248-2). No isoforms are annotated in the supplied record; this does not establish that all specimens contain one molecular form (UniProt Q9UBP4: isoforms 0). Check the antibody’s documented epitope, if available, and compare matched positive and negative sections before assigning an absent stain to epitope loss (general IHC practice).
How can I investigate DKK3 by multiplex IF alongside this IHC guide?
For the separate IF workflow, pair DKK3 with a neuronal-cell marker when examining caudate or hippocampus, where neuronal cells show high tissue staining (HPA tissue IHC: High in neuronal cells). Choose spectrally separated fluorophores and assess unstained-tissue autofluorescence before selecting a channel, especially when weak DKK3 signal needs interpretation (general IF practice). If the antibody recognizes an intracellular epitope, use controlled permeabilisation to access the supported vesicular compartment; if the intended signal is extracellular, assess whether permeabilisation is needed (HPA subcellular: vesicles supported; UniProt Q9UBP4: Secreted; general IF practice). Confirm channel-specific signal with single-stain and secondary-only controls; the paraffin tissue-IHC caption supplies no IF fixation or dilution condition (datasheet A02248-2; general IF practice).
What should I change when DKK3 DAB staining is diffuse?
First examine a no-primary control for secondary-reagent or endogenous-peroxidase signal, and use a peroxidase block when appropriate for chromogenic detection (general IHC practice). The catalog example used 10% goat serum, 2 μg/ml primary antibody overnight at 4°C, and a DAB endpoint; these are tested example conditions, not proof that diffuse staining is specific (datasheet A02248-2). Titrate primary antibody around the documented concentration and keep DAB development consistent across matched sections (datasheet A02248-2; general IHC practice). Interpret diffuse extracellular signal cautiously because DKK3 is secreted and protein location can differ from the location of its RNA expression (UniProt Q9UBP4: Secreted; HPA tissue IHC: reliability description).
How should I score DKK3 staining across specimens? ⚠ ANSWER MARKED FOR VERIFICATION
Define the compartment and cell population before scoring, because DKK3 tissue staining is generally cytoplasmic and the protein is secreted (HPA tissue IHC: general cytoplasmic expression; UniProt Q9UBP4: Secreted). For cell-associated DAB, report an H-score or the percentage of positive cells within a prespecified cell population; for extracellular signal, report stained area or optical density per mm² of viable tissue separately (general IHC practice). Normalize each measure to its relevant denominator, such as all evaluable cells of that type or analyzed viable area, and hold imaging and threshold settings constant (general IHC practice). Record retrieval and development conditions, including EDTA pH 8.0, so technical variation can be distinguished from specimen differences (datasheet A02248-2; general IHC practice).
How do I distinguish genuine DKK3 staining from artefact?
Look for reproducible cytoplasmic staining in intact cells and assess any extracellular signal separately, consistent with general tissue staining and DKK3 secretion (HPA tissue IHC: general cytoplasmic expression; UniProt Q9UBP4: Secreted). High neuronal-cell staining in caudate or hippocampus can support assay performance, while germinal-center cells in lymph node are reported as not detected (HPA tissue IHC: positive and negative profiles). Question signal confined to section edges, necrotic regions, or a no-primary control; those patterns can reflect processing or endogenous-enzyme artefact (general IHC practice). Treat isolated nuclear staining cautiously because nuclear bodies have uncertain cellular-imaging support, and avoid equating local protein signal with local RNA production (HPA subcellular: nuclear bodies uncertain; HPA tissue IHC: reliability description).
Boster reagents
Best DKK3 / Dickkopf-related protein 3 IHC Antibodies
Both anti-DKK3 antibodies have human brain IHC images (catalog image captions); A02248-2 also lists IF/ICC applications and human, mouse, and rat reactivity (catalog applications/reactivity).
Real IHC data
Anti-DKK3 Antibody
Cat # A02248-2
Real IHC data
Anti-DKK3 Antibody (N-term)
Cat # A02248-1
A02248-1 shows DAB staining in formalin-fixed, paraffin-embedded human brain (catalog image caption) and lists human IHC-P use (catalog applications/reactivity). A02248-2 shows DAB staining in paraffin-embedded human brain after EDTA retrieval (catalog image caption) and lists IHC, IF, and ICC use with human, mouse, and rat reactivity (catalog applications/reactivity).
Which to pick: For human tissue IHC with paraffin-section paraffin sections, A02248-1 matches the preparation in its own image; its listed IHC-P dilution is 1:50–1:100 (catalog image caption; datasheet: IHC-P dilution). For IF/ICC or cross-species work, choose A02248-2 because it lists those applications and human, mouse, and rat reactivity; its listed IF dilution is 1:50 (catalog applications/reactivity; datasheet: IF dilution). A02248-2’s own IHC image supports paraffin-embedded human brain, but does not report the fixative (catalog image caption); both antibodies are polyclonal (catalog dilution_raw). The selected A02248-2 tissue-IHC caption documents paraffin sections, but does not specify the fixative (selected-SKU IHC image A02248-2).
Each figure is that product's own IHC / IF validation image from its datasheet.
References
- UniProt Consortium. UniProt entry Q9UBP4 (DKK3_HUMAN, Dickkopf-related protein 3).
- Human Protein Atlas. DKK3 tissue IHC expression (reliability: Approved).
- Human Protein Atlas. DKK3 subcellular location (ICC-IF): Mainly localized to vesicles. In addition localized to the nuclear bodies and cytosol..
- Human Protein Atlas. DKK3 antibody validation summary (2 antibodies).
- Dickkopf-3 enhances the chondroprotective effect of chondrogenic progenitor cells in a rat model of posttraumatic osteoarthritis. Journal of orthopaedic surgery and research 2025 — PMC12645725.
- DKK3 Expression in Glioblastoma: Correlations with Biomolecular Markers. International journal of molecular sciences 2024 — PMC11012478.
- Aberrant DKK3 expression in the oral leukoplakia and oral submucous fibrosis: a comparative immunohistochemical study. European journal of histochemistry : EJH 2016 — PMC4933828.
- MiR-425 Promotes Migration and Invasion in Bladder Cancer by Targeting Dickkopf 3. Journal of Cancer 2020 — PMC7150467.
- PubMed PMID:10570958 — UniProt-cited evidence.
- PubMed PMID:10652205 — UniProt-cited evidence.
- PubMed PMID:11814687 — UniProt-cited evidence.
Immunohistochemistry protocol sheet for DKK3 (Dickkopf-related protein 3). Expected localisation Cytoplasmic staining (HPA tissue IHC); secreted (UniProt). Antigen retrieval: EDTA pH 8.0 HIER, heat-mediated (datasheet A02248-2). Validated IHC antibody: A02248-2 at 1:50 recommended; image 2 μg/ml (the product's own IHC validation image is shown). Controls (HPA): positive Caudate (Neuronal cells); negative Lymph node. IHC-P workflow on paraffin sections; fixative unspecified. Protocol steps: 1. Sample: Paraffin-embedded human brain tissue; fixative not specified (datasheet A02248-2); 2. Fixation: Image fixative and duration unreported (datasheet A02248-2); verify before use.; 3. Sectioning: 4–5 µm sections on charged slides (standard); 4. Deparaffinisation: Xylene, graded ethanol series to water (standard); 5. Antigen retrieval: Heat retrieval: EDTA pH 8.0 (datasheet A02248-2); 20 min, 95–100 °C (standard); 6. Peroxidase block: 3% H2O2, 10 min , room temperature (standard); 7. Blocking: 10% goat serum (datasheet A02248-2); 8. Primary antibody: Rabbit anti-DKK3, 1:50 recommended; image 2 μg/ml (datasheet A02248-2); 9. Primary incubation: Overnight at 4 °C (datasheet A02248-2). Watch for: Fixation: Keep fixation consistent across paraffin sections (standard IHC practice; not target-specific); Caveat: Secreted DKK3 may stain away from RNA-positive cells (HPA tissue IHC); Isoform / epitope: No isoforms annotated; mature chain starts at 22 (UniProt); Regulation: Expression regulation is not specified (UniProt record). Evidence: UniProt Q9UBP4, HPA tissue IHC · Approved, HPA ICC-IF · Mainly localized to vesicles. In addition localized to the nuclear…, Datasheet A02248-2, PMC12645725, PMC11012478. QR code links to https://www.bosterbio.com/bosterbio-gene-info-cards/DKK3/immunohistochemistry-ihc-guide.